Walgreens stock (NASDAQ:WBA) gained momentum following renewed speculation about a potential acquisition by private equity ...

The firm owned 15,738 shares of the pharmacy operator’s stock after buying an additional 5,447 shares during the period. Greenleaf Trust’s holdings in Walgreens Boots Alliance were worth $ ...

Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio Published first on TheFly – the ultimate source for real-time, market-moving ...

Walgreens Boots Alliance shares sank Friday after the pharmacy chain suspended its quarterly dividend to shore up its finances while it works to turn around its business. The company said it needs ...

How to calculate the intrinsic value of a stock? Key considerations in the ... continuous assessment of its strategic projects. Walgreens Boots Alliance omitted a chronology showing when it would ...

Walgreens Boots Alliance, Inc. investors have had a wild 2025 so far. Earlier this month, the beleaguered stock (Nasdaq: WBA) soared 25% after beating Q1 2025 expectations on revenue and earnings ...

Shares of Walgreens Boots Alliance dropped 10% Friday, after the pharmacy chain suspended quarterly dividends, citing the need for cash amid litigation and turnaround efforts. The Justice ...

The drop wiped out a brief rally the shares had after Walgreens reported better than expected earnings earlier this month. The stock has now shed more than half its value since last spring ...

Walgreens (WBA) shares fell sharply in Friday's pre-market trading after the company suspended its quarterly dividend. This move comes as the pharmaceutical retailer implements a turnaround strategy, ...

The news has evidently raised concerns among investors, leading to the decline in Walgreens' stock price during today's trading session. Walgreens Boots Alliance has not provided a timeline for when ...

Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on ...